142 related articles for article (PubMed ID: 11802199)
1. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.
Manne U; Jhala NC; Jones J; Weiss HL; Chatla C; Meleth S; Suarez-Cuervo C; Grizzle WE
Clin Cancer Res; 2004 Mar; 10(5):1743-52. PubMed ID: 15014027
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
[TBL] [Abstract][Full Text] [Related]
5. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
Lim YJ; Kim YH; Ahn GH; Chun HK; Jang WY; Lee JH; Son HJ; Rhee PL; Kim JJ; Paik SW; Yoo BC; Rhee JC
Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
[TBL] [Abstract][Full Text] [Related]
7. Relationship among p53, stage, and prognosis of large bowel cancer.
Nathanson SD; Linden MD; Tender P; Zarbo RJ; Jacobsen G; Nelson LT
Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229
[TBL] [Abstract][Full Text] [Related]
8. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
[TBL] [Abstract][Full Text] [Related]
9. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE
Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of colorectal carcinomas using tissue microarrays: cell cycle regulatory proteins p21, p27, and p53 as immunohistochemical prognostic markers in univariate and multivariate analysis.
Prall F; Ostwald C; Nizze H; Barten M
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):111-21. PubMed ID: 15354735
[TBL] [Abstract][Full Text] [Related]
11. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
12. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
Cheng JD; Werness BA; Babb JS; Meropol NJ
Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas.
Tenjo T; Toyoda M; Okuda J; Watanabe I; Yamamoto T; Tanaka K; Ohtani M; Nohara T; Kawasaki H; Tanigawa N
Oncology; 2000; 58(1):45-51. PubMed ID: 10644940
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage.
Georgiou L; Minopoulos G; Lirantzopoulos N; Fiska-Demetriou A; Maltezos E; Sivridis E
J Surg Res; 2006 Mar; 131(1):118-23. PubMed ID: 16325858
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
[TBL] [Abstract][Full Text] [Related]
19. Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
Zlobec I; Steele R; Michel RP; Compton CC; Lugli A; Jass JR
Mod Pathol; 2006 Sep; 19(9):1236-42. PubMed ID: 16741523
[TBL] [Abstract][Full Text] [Related]
20. Prognostic markers for colorectal cancer: expression of P53 and BCL2.
Pereira H; Silva S; Julião R; Garcia P; Perpétua F
World J Surg; 1997 Feb; 21(2):210-3. PubMed ID: 8995081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
